OPEB - Medicare Part D Subsidy (Retiree Drug Subsidy) Recognition
Recording the Medicare Part D retiree drug subsidy received from CMS (Centers for Medicare & Medicaid Services) when the employer's retiree prescription drug benefit is at least actuarially equivalent to Medicare Part D.
| Account Name | Type | Debit ($) | Credit ($) |
|---|---|---|---|
| Cash / Receivable - Medicare Part D Retiree Drug Subsidy | Asset (+) | 2,850,000.00 | - |
| OPEB Expense - Reduced by Medicare Part D Subsidy | Expense (-) | - | 2,850,000.00 |
💡 Accountant's Note
The Medicare Prescription Drug, Improvement and Modernization Act of 2003 created a retiree drug subsidy (RDS) — CMS pays employers 28% of allowable drug costs between $250 and $8,000 per Medicare-eligible retiree per year whose employer plan is 'actuarially equivalent' to standard Medicare Part D. The subsidy is non-taxable under IRC Section 139A. Employers must: (1) Apply for the subsidy and receive attestation from an actuary that their plan is actuarially equivalent, (2) Submit annual reconciliation to CMS, and (3) Credit the subsidy against NPPBC (reducing OPEB expense). Under ASC 715 ASU 2010-06, the subsidy is reflected in the APBO as a reduction to projected benefit payments.
Practitioner & Systems Framework
💻 ERP Architecture
The Medicare Part D subsidy election (RDS vs. Employer Group Waiver Plan vs. stand-alone Part D for retirees) is a complex strategic decision. Many employers have eliminated the RDS by moving to Employer Group Waiver Plans (EGWP) which provide retirees Part D benefits through a Medicare-contracted plan — often more cost-effective and reducing APBO significantly. The subsidy receivable from CMS is typically received 45-90 days after each subsidy period.
⚠️ Audit Flags
Auditors verify the actuarial equivalence attestation is current (required annually). The drug cost data submitted to CMS must match the claims data from the pharmacy benefit manager (PBM). Significant variances between estimated and actual subsidy amounts require reconciliation analysis. Companies transitioning from RDS to EGWP must assess the impact on the APBO as a plan amendment.
📄 Required Documentation
CMS actuarial equivalence attestation, RDS application and approval from CMS, drug cost data by Medicare-eligible retiree, RDS calculation and payment records from CMS, reconciliation of estimated vs. actual subsidy, IRC Section 139A non-taxability documentation, APBO impact of Part D subsidy assumption.
Professional Excel Template
Get the automated version of this entry. Includes built-in IFRS checks, VAT calculators, and SAP-ready upload formats.
Expert Analysis by Qusai Ahmad
General Accountant Supervisor & IFRS Specialist
Specialized in SAP GUI automation and Middle Eastern tax compliance. Building digital tools for the next generation of finance leaders.
Related Journal Entries
Pension & Employee Benefit Plans
Defined Benefit Plan - Service Cost (Current Year Benefit Earned)
Pension & Employee Benefit Plans
Defined Benefit Plan - Interest Cost on Projected Benefit Obligation
Pension & Employee Benefit Plans